10 Recent Oncology Drug Approvals

Slideshow

This slideshow summarizes recent US Food and Drug Administration approvals of new oncology drugs and oncology drug indications.

With rapid advancements in the field of oncology come frequent US Food and Drug Administration (FDA) approvals of new oncology drugs, as well as updates to the indications and warnings of existing therapies. In 2018, 17 of 59 new drug approvals (29%) were oncology-related, and the trend seems to continue so far in 2019. This slideshow highlights several newly approved oncology drugs or those with new indications in 2018 and the first quarter of 2019.

Recent Videos
Collaboration among different medical and research institutions may help improve quality of care for patients with cancer exposed to climate disasters.
A radiation oncologist discussed the theranostics treatment landscape and career opportunities in the field at the 2025 ACRO Summit.
Findings from the OVARIO study show that patients with HRR–deficient and BRCA-mutated disease benefitted the most from niraparib/bevacizumab maintenance.
Related Content